These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7228103)

  • 1. The estriol quotient in fibrocystic disease, a high-risk group for breast cancer.
    Bagli NP; Shah PN; Mistry SS
    Indian J Cancer; 1980 Dec; 17(4):201-4. PubMed ID: 7228103
    [No Abstract]   [Full Text] [Related]  

  • 2. [Urinary estrogen excretion in preneoplastic breast diseases].
    Kozhnazarova IuS; Mezinova NN; Remizova MG; Ikhsanova ST
    Vopr Onkol; 1972; 18(10):23-6. PubMed ID: 4662530
    [No Abstract]   [Full Text] [Related]  

  • 3. [Examination of the luteotropic hormone activity of blood and urinary steroid excretion in diseases of the breast].
    Márton Z; Gáti I; Doszpod J; Preisz J; Kecskés L
    Arch Geschwulstforsch; 1969; 34(2):179-87. PubMed ID: 5407886
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of age and menopause duration on the excretion of steroid hormones in precancerous conditions and cancer of the breast].
    Bogdanova AG
    Vopr Onkol; 1974 Oct; 20(7):13-8. PubMed ID: 4277856
    [No Abstract]   [Full Text] [Related]  

  • 5. [Urine catecholamine content in patients with malignant and benign breast neoplasms].
    Arsiriĭ SA
    Vopr Onkol; 1969; 15(7):50-3. PubMed ID: 5811140
    [No Abstract]   [Full Text] [Related]  

  • 6. Benign breast disease: estriol proportions and family history of breast cancer.
    Vakil DV; Morgan RW; Elinson L
    Cancer Detect Prev; 1981; 4(1-4):517-23. PubMed ID: 7349818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fibrocystic mastopathy and cancer of the breast. About 111 cases].
    Beyrouti MI; Beyrouti R; Khabir A; Ben Amar M; Frikha F; Dhieb N; Damak D; Abid M; Affes N; Boujelben S; Frikha M
    Tunis Med; 2006 Oct; 84(10):626-31. PubMed ID: 17193854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The level of follicle stimulating activity in precancer and cancer of the breast].
    Iskakova KI; Mezinova NN
    Vopr Onkol; 1973; 19(9):15-9. PubMed ID: 4788392
    [No Abstract]   [Full Text] [Related]  

  • 9. [Endocrinological aspects of fibrocystic mastopathy].
    Angelia A; Dogliotti L; Borretta G; Violino PL
    Recenti Prog Med; 1982 Jan; 72(1):31-64. PubMed ID: 7043677
    [No Abstract]   [Full Text] [Related]  

  • 10. Tryptophan metabolism in patients with breast cancer.
    Poulter JM; Dickerson JW; White WF
    Acta Vitaminol Enzymol; 1985; 7(1-2):93-7. PubMed ID: 4036762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics in the correlation of ovarian cycle hormones in mastopathy and breast cancer].
    Kuz'mina ZV; Shapoukhova KS; Murav'eva NI; Goncharova MG; Molodyk AA
    Vestn Akad Med Nauk SSSR; 1979; (2):60-4. PubMed ID: 419869
    [No Abstract]   [Full Text] [Related]  

  • 12. [Genetic factors in breast cancer].
    Levshin VF
    Sov Med; 1979 Sep; (9):72-7. PubMed ID: 505157
    [No Abstract]   [Full Text] [Related]  

  • 13. Mammary cancer risk: circulating TSH and prolactin, fibrocystic breast disease in chronoepidemiologic perspective.
    Tarquini B; Benvenuti M; Legnaioli M; Bazzani M; Cagnoni M; Halberg F
    Cancer Detect Prev; 1981; 4(1-4):525-34. PubMed ID: 7349819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer].
    Magnusson C; Weiderpass E
    Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer risk with cyst type in cystic disease of the breast. Larger study found no association between cyst type and breast cancer.
    Dixon JM; McDonald C; Elton RA; Miller WR
    BMJ; 1997 Aug; 315(7107):545-6. PubMed ID: 9329317
    [No Abstract]   [Full Text] [Related]  

  • 16. Endocrine influences on human mammary cancer formation. A critique.
    Lemon HM
    Cancer; 1969 Apr; 23(4):781-90. PubMed ID: 4304777
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and biochemical studies on methylxanthine-related fibrocystic breast disease.
    Minton JP; Abou-Issa H; Reiches N; Roseman JM
    Surgery; 1981 Aug; 90(2):299-304. PubMed ID: 7256542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions.
    Masood S
    Clin Lab Med; 2005 Dec; 25(4):713-31, vi. PubMed ID: 16308088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Female breast cancer: distribution, risk factors, and effect of steroid contraception.
    Lyle KC
    Obstet Gynecol Surv; 1980 Jul; 35(7):413-27. PubMed ID: 7402507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary steroids and breast disease.
    Gleave EN; Griffiths K; Cameron E; Wilson D; Campbell H; Forrest AP
    Br J Surg; 1969 Aug; 56(8):627. PubMed ID: 5797766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.